But, Switzerland rejected it.
https://healthpolicy-watch.news/switzerland-nixes-astrazeneca-vaccine-until-more-evidence-is-obtained-other-eu-countries-rule-out-vaccine-for-older-people/
"Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. "
WHO approves AstraZeneca/Oxford Covid-19 vaccine for emergency use, page-3
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$286.28 |
Change
1.180(0.41%) |
Mkt cap ! $138.6B | |||
| Open | High | Low | Value | Volume |
| $285.01 | $287.35 | $283.85 | $246.0M | 861.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2265 | $285.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $286.28 | 4885 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |